Prevalence of Erectile Dysfunction in Male Cancer: a Systematic Review and Meta-Analysis of Cross-Sectional Studies

Review (43 studies, n=19,329) participants found prevalence of erectile dysfunction is particularly high (40.72%) and may be influenced by neurovascular damage associated with treatment, hormonal therapy systemic chemo- or radiation therapy, as well as by psychological factors.

British Journal of General Practice